← Eichor
Condition: Spontaneous Bacterial Peritonitis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Spontaneous Bacterial Peritonitis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Faecal Microbiota Transplantation for Liver Cirrhosis
Phase 2/Phase 3 · 1 location(s) · University of Aarhus · NCT04932577
Oral Gemifloxacin Versus Intravenous Cefotaxime in Treatment of Spontaneous Bacterial Peritonitis
Phase 3 · 1 location(s) · Tanta University · NCT04168099
Efficacy of Conventional Dose Protocol vs Low Dose Protocol Albumin Use in Patients With Cirrhosis and High Risk Spontan
NA · 1 location(s) · Institute of Liver and Biliary Sciences, India · NCT06026267
Norfloxacin With Itopride Versus Norfloxacin in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis
Phase 3 · 1 location(s) · Tanta University · NCT04161768
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.